Moderna MRNA has outperformed the market over the past 10 years by 35.41% on an annualized basis producing an average annual return of 45.84%. Currently, Moderna has a market capitalization of $76.93 billion.
Buying $1000 In MRNA: If an investor had bought $1000 of MRNA stock 10 years ago, it would be worth $44,497.78 today based on a price of $200.24 for MRNA at the time of writing.
Moderna’s Performance Over Last 10 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.